Table 2 Patient characteristics of CCRT and CCRT + AC subgroups after propensity score matching
CCRT (n = 55) | CCRT + AC (n = 55) | P | |
|---|---|---|---|
Age (year) | 0.849 | ||
≤54 | 28 (50.9%) | 30 (54.5%) | |
>54 | 27 (49.1%) | 25 (45.5%) | |
ECOG | 0.284 | ||
0 | 18 (32.7%) | 12 (21.8%) | |
1 | 37 (67.3%) | 43 (78.2%) | |
Grade | 0.398 | ||
II | 13 (23.6%) | 11 (20.0%) | |
III | 21 (38.2%) | 28 (50.9%) | |
unknown | 21 (38.2%) | 16 (29.1%) | |
Hgb (g/L) | 0.567 | ||
≤117 | 27 (49.1%) | 31 (56.4%) | |
>117 | 28 (50.9%) | 24 (43.6%) | |
HPV | 0.381 | ||
negative | 7 (12.7%) | 3 (5.5%) | |
positive | 42 (76.4%) | 44 (80.0%) | |
unknown | 6 (10.9%) | 8 (14.5%) | |
Tumor-diameter | 0.690 | ||
≤4 | 21 (38.2%) | 18 (32.7%) | |
>4 | 34 (61.8%) | 37 (67.3%) | |
CCT cycles | 0.829 | ||
≤3 | 15 (27.3%) | 14 (25.5%) | |
>3 | 40 (72.7%) | 41 (74.5%) |